Skip to content

A randomized, controlled trial comparing vertical discontinuous suture of pampiniform external hemorrhoids combined with Milligan-Morgan versus Milligan-Morgan in the treatment of mixed hemorrhoids

A randomized, controlled trial comparing vertical discontinuous suture of pampiniform external hemorrhoids combined with Milligan-Morgan versus Milligan-Morgan in the treatment of mixed hemorrhoids

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300070244
Enrollment
Unknown
Registered
2023-04-06
Start date
2023-04-15
Completion date
Unknown
Last updated
2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

mixed hemorrhoids

Interventions

test group:vertical discontinuous suture combined with Milligan-Morgan

Sponsors

The First Affiliated Hospital of Zhengzhou University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. The clinical manifestation of mixed hemorrhoids is that the symptoms of internal hemorrhoids and external hemorrhoids coexist. Among them, internal hemorrhoids are internal hemorrhoids of stage ii (degree) or higher; 2. The patient has evaluable clinical symptoms such as bleeding, perianal mass prolapse, perianal moisture, itching, pain, etc.; 3. Patients aged 20 to 70 years without obvious surgical contraindications; 4. The patient has informed consent, good compliance, and can cooperate to complete all clinical research content.

Exclusion criteria

Exclusion criteria: 1. Combined with rectal canal inflammation; 2. Combined with inflammatory bowel disease; 3. Purulent infection around the anorectal canal, such as anal fistula, anal sinusitis, perianal abscess, etc; 4. Intestinal infectious diseases (such as dysentery); 5. Definitely diagnosed with outlet obstructive constipation; 6. Complicated with irritable bowel syndrome; 7. Patients with obvious symptoms of anxiety or depression, women with menopausal syndrome; 8. Patients with obvious surgical contraindications such as coagulopathy.

Design outcomes

Primary

MeasureTime frame
Efficiency rate;Postoperative hospitalization days;Postoperative complications;

Secondary

MeasureTime frame
Postoperative anal function;Six months post-operative Quality of Life scale;Evaluation of satisfaction rate of patients half a year after operation;

Countries

China

Contacts

Public ContactZhang Zhiyong

The First Affiliated Hospital of Zhengzhou University

zzuzzy2003@163.com+86 13837176135

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026